These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12866033)

  • 1. Human pHyde is not a classical tumor suppressor gene in prostate cancer.
    Porkka KP; Nupponen NN; Tammela TL; Vessella RL; Visakorpi T
    Int J Cancer; 2003 Sep; 106(5):729-35. PubMed ID: 12866033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral-mediated pHyde gene transfer and cisplatin additively inhibit human prostate cancer growth by enhancing apoptosis.
    Lu Y; Zhang X; Beheshti B; Zhang J
    Prostate; 2009 Feb; 69(3):234-48. PubMed ID: 19016247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma.
    Cordon-Cardo C; Koff A; Drobnjak M; Capodieci P; Osman I; Millard SS; Gaudin PB; Fazzari M; Zhang ZF; Massague J; Scher HI
    J Natl Cancer Inst; 1998 Sep; 90(17):1284-91. PubMed ID: 9731735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.
    Guan M; Zhou X; Soulitzis N; Spandidos DA; Popescu NC
    Clin Cancer Res; 2006 Mar; 12(5):1412-9. PubMed ID: 16533763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas.
    Chi SG; deVere White RW; Muenzer JT; Gumerlock PH
    Clin Cancer Res; 1997 Oct; 3(10):1889-97. PubMed ID: 9815578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression and gene amplification of BAG-1L in hormone-refractory prostate cancer.
    Mäki HE; Saramäki OR; Shatkina L; Martikainen PM; Tammela TL; van Weerden WM; Vessella RL; Cato AC; Visakorpi T
    J Pathol; 2007 Aug; 212(4):395-401. PubMed ID: 17503439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and copy number analysis of TRPS1, EIF3S3 and MYC genes in breast and prostate cancer.
    Savinainen KJ; Linja MJ; Saramäki OR; Tammela TL; Chang GT; Brinkmann AO; Visakorpi T
    Br J Cancer; 2004 Mar; 90(5):1041-6. PubMed ID: 14997205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity.
    Jing C; El-Ghany MA; Beesley C; Foster CS; Rudland PS; Smith P; Ke Y
    J Natl Cancer Inst; 2002 Apr; 94(7):482-90. PubMed ID: 11929948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-4 receptor-targeted cytotoxin therapy of androgen-dependent and -independent prostate carcinoma in xenograft models.
    Husain SR; Kawakami K; Kawakami M; Puri RK
    Mol Cancer Ther; 2003 Mar; 2(3):245-54. PubMed ID: 12657719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gene for polycomb group protein enhancer of zeste homolog 2 (EZH2) is amplified in late-stage prostate cancer.
    Saramäki OR; Tammela TL; Martikainen PM; Vessella RL; Visakorpi T
    Genes Chromosomes Cancer; 2006 Jul; 45(7):639-45. PubMed ID: 16575874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF1alpha isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation.
    Monsef N; Soller M; Panagopoulos I; Abrahamsson PA
    BMC Cancer; 2010 Jul; 10():385. PubMed ID: 20663134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells.
    Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P
    Am J Pathol; 2003 Aug; 163(2):543-52. PubMed ID: 12875974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis induction in prostate cancer cells by a novel gene product, pHyde, involves caspase-3.
    Zhang X; Steiner MS; Rinaldy A; Lu Y
    Oncogene; 2001 Sep; 20(42):5982-90. PubMed ID: 11593405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
    Chakrabarti R; Robles LD; Gibson J; Muroski M
    Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of prostate cancer by an adenovirus expressing a novel tumor suppressor gene, pHyde.
    Steiner MS; Zhang X; Wang Y; Lu Y
    Cancer Res; 2000 Aug; 60(16):4419-25. PubMed ID: 10969787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
    Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
    Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer.
    Linja MJ; Savinainen KJ; Saramäki OR; Tammela TL; Vessella RL; Visakorpi T
    Cancer Res; 2001 May; 61(9):3550-5. PubMed ID: 11325816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of drs mRNA in human prostate carcinomas.
    Kim CJ; Shimakage M; Kushima R; Mukaisho K; Shinka T; Okada Y; Inoue H
    Hum Pathol; 2003 Jul; 34(7):654-7. PubMed ID: 12874760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.